MYC and breast carcinoma: In ER + breast cancer, similarly, MYC overexpressed tumours with high ATR levels are associated with worse survival (p < 0.001) (Fig. 1d) including in patients who received endocrine therapy (Supplementary Figs. S2B and S2F).